Orbimed Advisors LLC filed its 13F report for Q2 2026 on August 14, 2026. The portfolio totaled 5.37 B reflecting a +6.83% change from the prior quarter, spanning 128 assets. The top 10 holdings comprised 43.4% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 31 new positions and 20 complete exits.
Items:
Total Value:
| Issuer Name | Class | Value | Shares | Option Type |
|---|
Orbimed Advisors submitted their Form 13F-HR for the Q2 2026 period on 08/14/2026. This was the only submission for the quarter.
In the Q2 2026 filing, Orbimed Advisors reported a managed portfolio value of 5.4 B, consisting of 129 individual positions.
This page displays the raw filing documents. To see which stocks Orbimed Advisors bought or sold during Q2 2026, please visit Orbimed Advisors's Portfolio Analysis page.